QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG.
- DOI
- 10.3389/fmicb.2022.825021
- Published
- 2022
- Container
- Frontiers in microbiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fmicb.2022.825021,
title = {QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG.},
author = {Carrère-Kremer S and Kolia-Diafouka P and Pisoni A and Bolloré K and Peries M and Godreuil S and Bourdin A and Van de Perre P and Tuaillon E},
year = {2022},
journal = {Frontiers in microbiology},
doi = {10.3389/fmicb.2022.825021},
url = {https://doi.org/10.3389/fmicb.2022.825021}
}RIS
TY - JOUR TI - QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG. AU - Carrère-Kremer S AU - Kolia-Diafouka P AU - Pisoni A AU - Bolloré K AU - Peries M AU - Godreuil S AU - Bourdin A AU - Van de Perre P AU - Tuaillon E PY - 2022 JO - Frontiers in microbiology DO - 10.3389/fmicb.2022.825021 UR - https://doi.org/10.3389/fmicb.2022.825021 ER -
APA
S, C., P, K., A, P., K, B., M, P., S, G., A, B., P, V. D. P., & E, T. (2022). QuantiFERON-TB Gold Plus Assay in Patients With Latent vs. Active Tuberculosis in a Low Incidence Setting: Level of IFN-γ, CD4/CD8 Responses, and Release of IL-2, IP-10, and MIG.. Frontiers in microbiology. https://doi.org/10.3389/fmicb.2022.825021
Source records
- pubmed · retrieved 2026-09-26T19:10:37.370Z